| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 32,462 | 31,518 | 34,299 | 37,425 | | Cost of Revenue | 16,968 | 17,614 | 14,865 | 19,484 | | | Gross Profit | 15,494 | 13,904 | 19,434 | 17,941 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 10,532 | 10,106 | 15,009 | 12,490 | | Non Recurring | 6,800 |
-
|
-
| 74,154 | | Others | 2,366 | 2,422 | 2,372 | 2,207 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (4,204) | 1,376 | 2,053 | (70,910) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (68) | 20 | 151 | 510 | | Earnings Before Interest And Taxes | (4,272) | 1,396 | 2,204 | (70,400) | | Interest Expense | 1,111 | 1,226 | 1,303 | 1,766 | | Income Before Tax | (5,383) | 170 | 901 | (72,166) | | Income Tax Expense | (1,786) | 72 | 360 | (8,713) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (3,597) | 98 | 541 | (63,453) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (3,597) | 98 | 541 | (63,453) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($3,597) | $98 | $541 | ($63,453) |
|
0.26% Nasdaq 
Income Statement
